Selective use of low osmolality contrast agents: cost and benefits
- PMID: 3136507
Selective use of low osmolality contrast agents: cost and benefits
Erratum in
- Radiol Technol 1988 Sep-Oct;60(1):60
Abstract
Recently introduced low osmolality contrasts produce less pain on injection and decrease other adverse side effects of angiography; however, converting completely to these agents is prohibitively expensive. Reserving low osmolality contrasts for high risk patients can provide a marked reduction in the increased cost associated with low osmolality contrasts, while at the same time reducing overall adverse side effects.
Similar articles
-
Safety and cost effectiveness of high-osmolality as compared with low-osmolality contrast material in patients undergoing cardiac angiography.N Engl J Med. 1992 Feb 13;326(7):425-30. doi: 10.1056/NEJM199202133260701. N Engl J Med. 1992. PMID: 1732769 Clinical Trial.
-
Decision analysis to assess cost-effectiveness of low-osmolality contrast medium for intravenous urography.Am J Hosp Pharm. 1992 Mar;49(3):577-84. Am J Hosp Pharm. 1992. PMID: 1598930
-
Evaluation of intravascular low-osmolality contrast agents.Clin Pharm. 1986 Nov;5(11):877-91. Clin Pharm. 1986. PMID: 3780159
-
Low-osmolality versus high-osmolality contrast material.Curr Opin Radiol. 1992 Apr;4(2):9-15. Curr Opin Radiol. 1992. PMID: 1554592 Review.
-
Preston M. Hickey memorial lecture. Ionic and nonionic iodinated contrast media: evolution and strategies for use.AJR Am J Roentgenol. 1990 Aug;155(2):225-33. doi: 10.2214/ajr.155.2.2115244. AJR Am J Roentgenol. 1990. PMID: 2115244 Review.